Cargando…
The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents
Breast cancer (BC) treatment frequently involves microtubule-targeting agents (MTAs), such as paclitaxel, that arrest cells in mitosis. Sensitivity to MTAs is defined by a subset of pro- and anti-apoptotic BCL2 family proteins controlling mitochondrial apoptosis. Here, we aimed to determine their pr...
Autores principales: | Karbon, Gerlinde, Haschka, Manuel D., Hackl, Hubert, Soratroi, Claudia, Rocamora-Reverte, Lourdes, Parson, Walther, Fiegl, Heidelinde, Villunger, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668920/ https://www.ncbi.nlm.nih.gov/pubmed/34903710 http://dx.doi.org/10.1038/s41419-021-04415-y |
Ejemplares similares
-
MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment
por: Haschka, Manuel D., et al.
Publicado: (2020) -
Perturbing mitosis for anti‐cancer therapy: is cell death the only answer?
por: Haschka, Manuel, et al.
Publicado: (2018) -
The NOXA–MCL1–BIM axis defines lifespan on extended mitotic arrest
por: Haschka, Manuel D., et al.
Publicado: (2015) -
BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis
por: Wensveen, Felix M., et al.
Publicado: (2013) -
Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa
por: Naik, Edwina, et al.
Publicado: (2007)